Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease

Por Deshpande, Devyani, Pasipanodya, Jotam G., Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases

Por Deshpande, Devyani, Srivastava, Shashikant, Musuka, Sandirai, Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium av...

Por Deshpande, Devyani, Srivastava, Shashikant, Meek, Claudia, Leff, Richard, Gumbo, Tawanda
Publicado em 2010

Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium avium Infection

Por Deshpande, Devyani, Srivastava, Shashikant, Meek, Claudia, Leff, Richard, Hall, Gerri S., Gumbo, Tawanda
Publicado em 2010

Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks

Por Srivastava, Shashikant, Deshpande, Devyani, Pasipanodya, Jotam, Nuermberger, Eric, Swaminathan, Soumya, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)

Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo

Por Deshpande, Devyani, Srivastava, Shashikant, Nuermberger, Eric, Pasipanodya, Jotam G., Swaminathan, Soumya, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)

A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way

Por Deshpande, Devyani, Srivastava, Shashikant, Nuermberger, Eric, Pasipanodya, Jotam G., Swaminathan, Soumya, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)

Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

Por Srivastava, Shashikant, Modongo, Chawanga, Siyambalapitiyage Dona, Chandima W., Pasipanodya, Jotam G., Deshpande, Devyani, Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground

Por Srivastava, Shashikant, Deshpande, Devyani, Pasipanodya, Jotam G., Thomas, Tania, Swaminathan, Soumya, Nuermberger, Eric, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)

Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps

Por Deshpande, Devyani, Srivastava, Shashikant, Pasipanodya, Jotam G., Bush, Stephen J., Nuermberger, Eric, Swaminathan, Soumya, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)

The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance

Por Schmalstieg, Aurelia M., Srivastava, Shashikant, Belkaya, Serkan, Deshpande, Devyani, Meek, Claudia, Leff, Richard, van Oers, Nicolai S. C., Gumbo, Tawanda
Publicado em 2012

Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests

Por Swaminathan, Soumya, Pasipanodya, Jotam G., Ramachandran, Geetha, Hemanth Kumar, A. K., Srivastava, Shashikant, Deshpande, Devyani, Nuermberger, Eric, Gumbo, Tawanda
Publicado no Clin Infect Dis (2016)

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

Por Ferro, Beatriz E., Srivastava, Shashikant, Deshpande, Devyani, Pasipanodya, Jotam G., van Soolingen, Dick, Mouton, Johan W., van Ingen, Jakko, Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

Por Ferro, Beatriz E., Srivastava, Shashikant, Deshpande, Devyani, Pasipanodya, Jotam G., van Soolingen, Dick, Mouton, Johan W., van Ingen, Jakko, Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

Por Ferro, Beatriz E., Srivastava, Shashikant, Deshpande, Devyani, Pasipanodya, Jotam G., van Soolingen, Dick, Mouton, Johan W., van Ingen, Jakko, Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model

Por Ferro, Beatriz E., Srivastava, Shashikant, Deshpande, Devyani, Sherman, Carleton M., Pasipanodya, Jotam G., van Soolingen, Dick, Mouton, Johan W., van Ingen, Jakko, Gumbo, Tawanda
Publicado no Antimicrob Agents Chemother (2016)

A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies

Por Srivastava, Shashikant, Pasipanodya, Jotam G., Ramachandran, Geetha, Deshpande, Devyani, Shuford, Stephen, Crosswell, Howland E., Cirrincione, Kayle N., Sherman, Carleton M., Swaminathan, Soumya, Gumbo, Tawanda
Publicado no EBioMedicine (2016)